Patient Guide: Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTMK-3475-03A
Status: NOT_YET_RECRUITING
Condition: Renal Cell Carcinoma, Clear Cell RCC
Phase: PHASE1, PHASE2

Loading interactive enrollment tools...

The full interactive experience will load momentarily